Josef Ozer

Josef Ozer

UNVERIFIED PROFILE

Are you Josef Ozer?   Register this Author

Register author
Josef Ozer

Josef Ozer

Publications by authors named "Josef Ozer"

Are you Josef Ozer?   Register this Author

16Publications

486Reads

16Profile Views

Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides.

Interdiscip Toxicol 2014 Sep 30;7(3):123-33. Epub 2014 Dec 30.

Department of Neurology, Boston University School of Medicine, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/intox-2014-0017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434105PMC
September 2014

Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples.

Rapid Commun Mass Spectrom 2011 Jun;25(12):1715-24

Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research & Development Groton Laboratories, Pfizer Inc., Groton, CT 06340, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rcm.5026DOI Listing
June 2011

Novel prodromal biomarkers that are symptomatic of injury require histopathologic or clinical chemistry anchors to characterize activity.

J Pharmacol Toxicol Methods 2009 Nov-Dec;60(3):321-2. Epub 2009 Jul 24.

Pfizer Global Research and Development, Pharmacokinetics, Dynamics, and Metabolism, 700 Chesterfield Parkway West, T2A, Chesterfield, MO 63017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vascn.2009.07.005DOI Listing
July 2010

Recommendations to qualify biomarker candidates of drug-induced liver injury.

Biomark Med 2010 Jun;4(3):475-83

Pfizer Global Research & Development, Pharmacokinetics, Dynamics & Metabolism, Andover, MA 01810, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.10.9DOI Listing
June 2010

Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.

Regul Toxicol Pharmacol 2010 Apr 10;56(3):237-46. Epub 2009 Nov 10.

Pfizer Global Research and Development, Pharmacokinetics, Dynamics, and Metabolism, 700 Chesterfield Parkway West, T2A, Chesterfield, MO 63017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yrtph.2009.11.001DOI Listing
April 2010

A guidance for renal biomarker lead optimization and use in translational pharmacodynamics.

Authors:
Josef S Ozer

Drug Discov Today 2010 Feb 21;15(3-4):142-7. Epub 2009 Dec 21.

Pfizer Global Research and Development, Pharmacokinetics, Dynamics, and Metabolism, St Louis, MO 63017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2009.12.001DOI Listing
February 2010

Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization.

J Chromatogr B Analyt Technol Biomed Life Sci 2009 Jul 28;877(22):2052-60. Epub 2009 May 28.

Pfizer Global Research and Development, Pharmacokinetics, Dynamics & Metabolism, 700 Chesterfield Parkway, St. Louis, MO 63017, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15700232090037
Publisher Site
http://dx.doi.org/10.1016/j.jchromb.2009.05.043DOI Listing
July 2009

The current state of serum biomarkers of hepatotoxicity.

Toxicology 2008 Mar 5;245(3):194-205. Epub 2007 Dec 5.

Safety Assessment, Merck Research Laboratories, West Point, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tox.2007.11.021DOI Listing
March 2008

Sp and GATA factors are critical for Apolipoprotein AI downstream enhancer activity in human HepG2 cells.

Gene 2003 Dec;323:31-42

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, 715 Albany Street, Building R-618, Boston, MA 02118, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gene.2003.08.014DOI Listing
December 2003